GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (SHSE:688331) » Definitions » Pre-Tax Income

RemeGen Co (SHSE:688331) Pre-Tax Income : ¥-1,588 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RemeGen Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. RemeGen Co's pretax income for the six months ended in Jun. 2024 was ¥-780 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-1,588 Mil. RemeGen Co's pretax margin was -105.52%.

During the past 6 years, RemeGen Co's highest Pretax Margin was 19.40%. The lowest was -2384.46%. And the median was -135.26%.


RemeGen Co Pre-Tax Income Historical Data

The historical data trend for RemeGen Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Pre-Tax Income Chart

RemeGen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial -430.28 -697.82 276.26 -998.83 -1,511.23

RemeGen Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -489.13 -509.70 -703.36 -807.87 -780.46

Competitive Comparison of RemeGen Co's Pre-Tax Income

For the Biotechnology subindustry, RemeGen Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RemeGen Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where RemeGen Co's Pre-Tax Income falls into.



RemeGen Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

RemeGen Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1502.346+0+-23.091+28.143+-13.935
=-1,511

RemeGen Co's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-780.733+0+-31.867+0+32.14
=-780

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ¥-1,588 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RemeGen Co  (SHSE:688331) Pre-Tax Income Explanation

RemeGen Co's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-780.46/739.656
=-105.52%

During the past 6 years, RemeGen Co's highest Pretax Margin was 19.40%. The lowest was -2384.46%. And the median was -135.26%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RemeGen Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of RemeGen Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


RemeGen Co Business Description

Traded in Other Exchanges
Address
58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.

RemeGen Co Headlines

No Headlines